The impact of pharmacist telephone follow-up on control of type-2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes mellitus.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT201212108612N1
- Lead Sponsor
- Research Center for Rational Use of Drugs, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
Inclusion Criteria: Type 2 diabetic patients using oral anti diabetic medications; age< 75 years; Hemoglobin A1c > 7%; Adequate literacy and ability to use the glucometer; Adequate physical (hearing) and cognitive competence
Exclusion Criteria
Patients requiring adjunct insulin therapy; Patients with concurrent heart failure (stage 4); Patients who fast in Ramadan
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin A1c. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: laboratory analysis.
- Secondary Outcome Measures
Name Time Method Medication adherence. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Morisky Medication Adherence Questionnaire.;Self-care activity. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Diabetes Self-care Activity Measure questionnaire.;Total Cholestrol. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: laboratory analysis.;LDL. Timepoint: Change from baseline (at the point of recruiting) LDL level at 3 months. Method of measurement: Laboratory analysis.;HDL. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Laboratory analysis.;Triglyceride. Timepoint: Baseline, After 3-month intervention, six months after intervention. Method of measurement: Laboratory analysis.